Skip to main content
. 2011 Jun;178(6):2708–2715. doi: 10.1016/j.ajpath.2011.02.021

Table 2.

Characteristics of CHC Patients with Electron Microscopy Analysis, LC3 Immunoblotting or LC3A and LC3B mRNA Assessment

Patients with electron microscopy analysis (n = 23) Patients with LC3 immunoblotting (n = 15) Patients with LC3A and LC3B mRNA assessment (n = 10) Patients with LAMP2 immunoblotting (n = 8)
Sex (male) 15 (65) 11 (73) 4 (40) 5 (63)
Age (years) 48 (23–74) 48 (20–74) 51 (33–66) 57 (33–69)
Body mass index (kg/m2) 24.7 (19.0–36.4) 25.3 (17.3–34.8) 24.7 (20.5–36.3) Not available
Serum levels at liver biopsy
 AST (×ULN) 1.7 (0.7–6.2) 1.4 (0.7–7.1) 2.1 (0.9–5.4) 1.8 (0.8–2.7)
 ALT (×ULN) 2.2 (0.6–8.4) 1.9 (0.8–9.4) 2.7 (1.1–5.6) 2.3 (1–4.3)
 γ-GT (×ULN) 1.5 (0.2–4.7) 1.8 (0.4–5.9) 1.8 (0.3–5.3) Not available
 Total cholesterol (mmol/L) 4.7 (2.5–7.2) 4.4 (2.9–6.5) 4.5 (3.1–5.1) Not available
 Triglycerides (mmol/L) 1.1 (0.4–3.7) 0.9 (0.5–1.8) 1.3 (0.5–1.8) Not available
 Glucose (mmol/L) 5.5 (4.2–16.3) 5.1 (3.4–7.2) 5.0 (3.8–6.4) Not available
 HCV RNA (log) 6.06 (4.94–7.77) 6.39 (4.37–7.38) 6.11 (5.79–7.17) Not available
HCV genotype (1-2-3-4) 10-2-7-4 11-2-1-1 5–0-5–0 5-0-1-0 (two not availables)
Histological analysis
 Activity grade 0-9-11-3 0-9-5-1 0-6-3-1 1-5-2–0
 (METAVIR A0, A1, A2, A3)
 Fibrosis stage 8-6-3-6 9-3-1-2 3-2-2-3 3-4-1–0
 (METAVIR F1, F2, F3, F4)
 Steatosis (% of hepatocytes) 20 (0–40) 10 (0–90) 45 (0–75) 15 (0–80)

Data are median (range) or frequency (%).

Fibrosis stage (METAVIR): F0 (absent); F1 (portal fibrosis), F2 (portal fibrosis with few septa), F3 (septal fibrosis), F4 (cirrhosis).

Necroinflammation grade (METAVIR): A0 (absent), A1 (mild), A2 (moderate), A3 (severe).

For ALT level, upper limit of normal is 34 IU/L in women and 45 IU/L in men. For AST level, upper limit of normal is 31 IU/L in women and 35 IU/L in men. For γ-GT level, upper limit of normal is 38 UI/L in women and 55 UI/L in men.

γ-GT, γ-glutamyl transferase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CHC, chronic hepatitis C; LAMP2, lysosome-associated membrane protein 2; LC3, light chain 3; ULN, upper limit of normal.